FORLANI, GRETA
 Distribuzione geografica
Continente #
NA - Nord America 9.026
EU - Europa 5.887
AS - Asia 4.029
SA - Sud America 392
AF - Africa 70
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.429
Nazione #
US - Stati Uniti d'America 8.896
IT - Italia 2.873
SG - Singapore 1.261
CN - Cina 978
UA - Ucraina 880
VN - Vietnam 573
HK - Hong Kong 460
TR - Turchia 448
SE - Svezia 447
DE - Germania 375
BR - Brasile 322
FI - Finlandia 289
IE - Irlanda 254
GB - Regno Unito 201
FR - Francia 195
RU - Federazione Russa 151
CA - Canada 75
IN - India 74
BD - Bangladesh 64
JP - Giappone 55
MX - Messico 46
PL - Polonia 42
BE - Belgio 37
AR - Argentina 32
NL - Olanda 29
ES - Italia 25
IQ - Iraq 22
AT - Austria 17
CZ - Repubblica Ceca 17
ZA - Sudafrica 17
AU - Australia 16
LT - Lituania 15
NG - Nigeria 15
EC - Ecuador 12
MA - Marocco 12
PK - Pakistan 10
SA - Arabia Saudita 10
VE - Venezuela 10
CH - Svizzera 9
ID - Indonesia 9
EG - Egitto 8
IR - Iran 7
AE - Emirati Arabi Uniti 6
EU - Europa 6
KR - Corea 6
PH - Filippine 6
UZ - Uzbekistan 6
AL - Albania 5
JO - Giordania 5
CO - Colombia 4
LU - Lussemburgo 4
MY - Malesia 4
CL - Cile 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GA - Gabon 3
HR - Croazia 3
KE - Kenya 3
MD - Moldavia 3
PE - Perù 3
PS - Palestinian Territory 3
PY - Paraguay 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GY - Guiana 2
HU - Ungheria 2
KH - Cambogia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
AO - Angola 1
BB - Barbados 1
BT - Bhutan 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
Totale 19.424
Città #
Milan 1.972
Fairfield 777
San Jose 732
Ashburn 696
Singapore 695
Jacksonville 691
Chandler 536
Woodbridge 533
Hong Kong 456
Dearborn 406
Houston 404
Ann Arbor 345
Seattle 311
Wilmington 298
Beijing 285
Dublin 251
Princeton 249
Cambridge 245
Izmir 205
Dallas 203
Nyköping 193
Boardman 158
New York 145
The Dalles 145
Dong Ket 143
Rome 127
Council Bluffs 125
Como 124
Lauterbourg 118
Ho Chi Minh City 110
Los Angeles 99
Chicago 90
Munich 83
Helsinki 74
San Diego 60
Orem 57
Santa Clara 54
Hanoi 52
Ogden 52
Tokyo 49
Guangzhou 46
London 46
San Mateo 46
São Paulo 45
Brussels 36
Kocaeli 32
Toronto 31
Warsaw 31
Hefei 30
Mexico City 30
Turku 27
Nanjing 26
Denver 24
Kunming 23
Verona 23
Frankfurt am Main 22
Jinan 21
San Francisco 21
Washington 21
Phoenix 20
Brooklyn 19
Norwalk 19
Buffalo 18
Chennai 17
Gallarate 17
Manchester 17
Shenzhen 17
Berlin 16
Shanghai 16
Varese 16
Abuja 15
Atlanta 15
Düsseldorf 15
Montreal 15
Stockholm 15
Johannesburg 14
Nuremberg 14
Haiphong 13
Hangzhou 13
Boston 12
Brno 12
Edinburgh 12
Mumbai 12
Amsterdam 11
Philadelphia 11
Pune 11
Vienna 11
Ankara 10
Falls Church 10
Kilburn 10
Magnago 10
Poplar 10
Shenyang 10
Changsha 9
Columbus 9
Fuzhou 9
Memphis 9
Nanchang 9
Naples 9
Da Nang 8
Totale 13.464
Nome #
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells 270
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state 247
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) 236
Investigating Human T Cell Lymphotropic Retrovirus (HTLV) tax function with molecular and immunophenotypic techniques 234
CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches 230
HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients 224
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1 217
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL 210
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation 205
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators 203
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells 203
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1 197
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL 191
Autoimmunità e Malattie Autoimmuni 189
CIITA-driven MHC class II expressing tumor cells as antigen presenting cell performers: Toward the construction of an optimal anti-tumor vaccine 189
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication 186
Adequate Antigen Availability (AAA) in antitumor immunity: Definition and consequences for novel strategies of tumor prevention and antitumor treatment 184
Biophysics and molecular physiology of membrane transport systems 183
Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation 181
Tumor Immunology meets Immunology: Modified cancer cells as professional APC for priming naïve tumor-specific CD4+ T cells 178
Modulation of the inward rectifier potassium channel IRK1 by the Ras signaling pathway 177
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation 176
The MHC class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation. 176
Probiotic Bifidobacterium lactis, anti-oxidant vitamin E/C and anti-inflammatory dha attenuate lung inflammation due to pm2.5 exposure in mice 174
Tripartite motif 22 and class II transactivator restriction factors: Unveiling their concerted action against retroviruses 174
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells 174
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1. 171
The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis 170
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma 169
-K448E mutation in the extracellular loop 5 rGAT1 gaba transporter induces alterations in interactions of substrates 167
New approaches of cancer vaccination and cancer immunotherapy based on the optimal stimulation of tumor-specific, MHC class II-restricted CD4+ T helper cells 166
The guanine nucleotide exchange factor Ras-GRF1 directly binds microtubules via DH-PH2 mediated interaction 165
The guanine nucleotide exchange factor Ras-GRF1 directly binds microtubules via DH-PH2 mediated interaction 165
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects 163
An episode of oral mucositis after the first administration of the ChAdOx1 COVID-19 vaccine 162
Role of anion-cation interactions on the pre-steady-state currents of the rat Na(+)-Cl(-)-dependent GABA cotransporter rGAT1 161
Altered sodium binding induced by K448E mutation in the extracellular loop 5 of GAT1 GABA transporter 160
CIITA dependent MHC class II IA expression in tumor cells triggers CD4 T cell protective and long lasting antitumor immunity 160
MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to and affecting Tax-2 intracellular localization 159
The MHC-II transactivator CIITA inhibits Tat-mediated HIV-1 LTR transactivation and virus replication in human U937 monocytic cells 158
Tax-1-mediated HTLV-1 replication and NF-kB activation is inhibited by the MHC-II transactivator CIITA 158
Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes 158
Tax-1-mediated NF-kB activation is inhibited by the MHC-II transactivator CIITA 157
Temperature effects on the presteady-state and transport-associated currents of GABA cotransporter rGAT1 157
Three kinds of currents in the canine betaine-GABA transporter BGT-1 expressed in Xenopus laevis oocytes 156
Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines 156
Electrophysiological properties of the canine betaine/GABA transporter BGT-1 expressed in Xenopus laevis oocytes. 155
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients 153
DNA ricombinante 152
Molecular and Cellular Correlates of the CIITA-Mediated Inhibition of HTLV-2 Tax-2 Transactivator Function Resulting in Loss of Viral Replication. 152
Na+ AND Cl- EFFECTS ON THE NEURONAL GABA COTRANSPORTER rGAT1 151
Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1 151
Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. 149
Nociceptor-specific gene deletion reveals a major role for Na(v)1.7 (PN1) in acute and inflammatory pain 149
HTLV-1 HBZ viral protein: A key player in HTLV-1 mediated diseases 149
Electrophysiological properties of the canine betaine/GABA transporter BGT-1 expressed in Xenopus laevis oocytes. 148
The MHC class II transactivator CIITA inhibits the persistent activation of NF-kB by Human T cell Lymphotropic Virus type-1 Tax-1 oncoprotein 148
Distinct subcellular localization of HTLV-1 HBZ oncoprotein in the ATL leukemic and HAM/TSP patients. 148
Na+ AND Cl- INTERACTIONS AT THE NEURONAL GABA COTRANSPORTER rGAT1 146
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1 146
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-kappa B by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein 146
Htlv-1 infection and pathogenesis: New insights from cellular and animal models 146
CIITA-transduced glioblastoma cells uncover a rich repertoire of clinically relevant tumor-associated HLA-II antigens 145
The MHC-II transactivator CIITA is a viral restriction factor against HIV-1 replication 144
CIITA-transfected tumor cells as potent, widely applicable anti-tumor vaccine due to their optimal triggering of long-lasting tumor-specific CD4+ T helper cells 143
Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization 142
pH sensitivity conferred to rGAT1 gaba transporter by mutations in the extracellular loop 5. 141
The MHC Class II transactivator, CIITA,is a viral restriction factor for human oncogenic retroviruses 141
Identification and characterization of proteins that, interacting with MeCP2, could be involved in Rett Syndrome 141
K448E mutation in the extracellular loop 5 of rgat1 gaba transporter induces alterations in interactions of substrates 140
The guanine nucleotide exchange factor RasGRF1 directly binds microtubules via DHPH2-mediated interaction 139
Modulation of extracellular signal-regulated kinases cascade by cronic Delta(99-tetrahydrocannabinol treatment 138
Association of the neuron specific Ras-exchange factor Ras-GRF1 with the microtubules cytoskeleton 137
The constitutive activation of NF-kB by HTLV-1 Tax-1 oncoprotein is inhibited by the MHC class II transactivator CIITA 136
Nociceptor-specific gene deletion using heterozygous Na(v)1.8-Cre recombinase mice 136
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine 134
Modulation of the inward rectifier potassium channel IRK1 by the Ras pathway 134
Host-retrovirus interaction: role of CIITA in the inhibition of HTLV-1 replication and oncogenic potential 134
The guanine nucleotide exchange factor Ras-GRF1 directly binds microtubules via DH-PH2 mediated interaction 134
Functional Characterization of CDKL5, a Novel Gene Involved in The Onset of Rett Syndrome and Infantile Spasms. 133
Mutations in specific aminoacid residues confer ph sensitivity to the rat gaba cotrasporter Gat1 131
Mutation K448E in the external loop 5 of rat GABA transporter rGAT1 induces pH sensitivity and alters substrates interactions 129
Modulation of the inward rectifier potassium channel IRK1 by the Ras pathway 129
Unveiling the hidden treasury: Ciita-driven mhc class ii expression in tumor cells to dig up the relevant repertoire of tumor antigens for optimal stimulation of tumor specific cd4+ t helper cells 129
The MHC-II transactivator CIITA is a viral restriction factor against HIV-1 replication 127
Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma 127
Modulation of the inward rectifier potassium channel IRK1 by the Ras signalling pathway 126
Modulation of the inward rectifier potassium channel IRK1 by the Ras pathway 126
Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T cell leukemia 124
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1 122
A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells 120
The MHC class II transactivator CIITA acts as a restriction factor for HIV in human myeloid cells. 120
The modulation of the inward rectifier potassium channel IRK1 by the Ras pathway 119
Modulation of the inward rectifier potassium channel IRK1 by the Ras signalling pathway 119
Functional characterization of CDKL5, a novel gene involved in Rett syndrome and infantile spams associated with mental retardation 118
Intracranic injection of CIITA-driven MHC-II positive glioblastoma cells induces an effective anti-tumor immune response in vivo: implication for new therapeutic strategies against the glioblastoma 117
The MHC-II Transactivator CIITA, a Viral Restriction Factor Targeting Human T-Cell Lymphotropic Virus Type 1 Tax-1 Function and Inhibiting Viral Replication. 117
Functional characterization of CDKL5, a novel gene involved in the onset of Rett Syndrome 117
Functional Characterization of CDKL5, a novel gene involved in the onset of Rett syndrome 116
Modulation of the inward rectifier potassium channel IRK1 by the Ras cascade 115
Totale 15.775
Categoria #
all - tutte 76.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021286 0 0 0 0 0 0 0 0 0 0 0 286
2021/20221.166 161 123 57 94 53 50 37 61 64 178 130 158
2022/20231.667 158 36 74 177 137 388 1 225 247 91 80 53
2023/20243.127 500 488 523 563 557 268 14 37 87 21 13 56
2024/20252.032 20 18 343 104 98 119 72 132 242 123 177 584
2025/20265.065 393 321 194 706 454 335 1.097 319 558 345 242 101
Totale 19.588